Who is sponsoring NCT05604456?

NCT05604456 is sponsored by Xiaohui Su.

What drugs are being tested in NCT05604456?

Interventions in NCT05604456: secondary ear reconstruction based on Nagata method.

What condition does NCT05604456 study?

NCT05604456 studies Secondary Ear Reconstructions Based on Nagata Method.

Is NCT05604456 still recruiting?

NCT05604456 is currently completed. Last updated 3 November 2022.

Last reviewed 2022-11-03 · How we verify

NCT05604456

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Secondary Ear Reconstructions Based on Nagata Method

Completed Last updated 3 November 2022

What this trial tests

trial testing secondary ear reconstruction based on Nagata method in Secondary Ear Reconstructions Based on Nagata Method in 7 participants. Completed in 1 October 2022.

Timeline

1 May 2022

Primary endpoint
1 September 2022

1 October 2022

Quick facts

Lead sponsor	Xiaohui Su
Status	Completed
Study type	OBSERVATIONAL
Enrollment	7
Start date	1 May 2022
Primary completion	1 September 2022
Estimated completion	1 October 2022
Sites	1 location across China

Drugs / interventions tested

secondary ear reconstruction based on Nagata method

Conditions studied

Secondary Ear Reconstructions Based on Nagata Method — all drugs for Secondary Ear Reconstructions Based on Nagata Method →

Sponsor

Xiaohui Su

Who can join

8 and older, any sex, with Secondary Ear Reconstructions Based on Nagata Method. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to provide a feasible surgical strategy based on Nagata method for patients who require secondary revision surgeries and to verify its long-term aesthetic outcomes. The main question it aims to answer is: • Whether ear reconstruction surgery based on Nagata method can improve the unsatisfactory outcomes of primary reconstruction surgery? Participants who had accepted secondary ear reconstruction based on Nagata method in our department will be required to received questionnaires in the follow-up and their photographs will be collected for reconstructed ear evaluation of its realness through convolutional neural network (CNN) models we previously developed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Secondary ear reconstruction based on the Nagata method after unsatisfactory microtia surgery outcomes.
Su XH, Ye J, Lei C, Wei SJ, et al · · 2023 · PMID 37924716 · DOI 10.1016/j.bjps.2023.10.075

Verify or expand the search:

Other Xiaohui Su trials

Trials by the same sponsor.

NCT06118216 — Costal Cartilage Donor-site Pain: Does Abdominal Muscle Infiltration Analgesia Work? · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05604456 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xiaohui Su
Last refreshed: 3 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing